Who invested in Chroma Therapeutics?
Chroma Therapeutics's investors include Abingworth, Wellcome Trust, Essex Woodlands Healthcare Partners, Nomura and Gilde Healthcare, and 2 more on record.

United Kingdom · Venture startup
Funding summaryUpdated 26 Oct 2026
$78Mraised across 2 rounds since 2006, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by chromatherapeutics.com
From Chroma Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Chroma Therapeutics's investors include Abingworth, Wellcome Trust, Essex Woodlands Healthcare Partners, Nomura and Gilde Healthcare, and 2 more on record.
Chroma Therapeutics has raised $78M across 2 rounds since 2006.
Chroma Therapeutics's most recent round was a Venture of $25M in Jun 2009.
Chroma Therapeutics's largest round on record is $53M (Series C), in Apr 2006.
Chroma Therapeutics's first round on record, in Apr 2006, was backed by Abingworth, Wellcome Trust and Essex Woodlands Healthcare Partners and 2 others.
Chroma Therapeutics's latest named round is a Venture, in Jun 2009.
Chroma Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.